EARLY REPERFUSION is desirable after myocardial infarction, because it is an effective way to reduce infarct size and improve cardiac tissue function. However, reperfusion itself results in neutrophil adhesion in the postcapillary venules and emigration into the interstitium, increased monolayer permeability, and abnormal vasoregulation (16, 34) . The pathogenesis of ischemia-reperfusion (I/RP) injury has been attributed to the production of oxygen-derived free radicals, often called reactive oxygen species (ROS), upon readmission of blood at reperfusion (19, 61) . Vascular endothelial cells (ECs) are the primary target for ROS generated by themselves immediately after reperfusion and by adherent leukocytes at later times in reperfusion (43, 61) .
In vitro hypoxia-reoxygenation (H/RO) studies with cultured ECs demonstrated that ROS production is increased shortly after reoxygenation (41, 53) and is dependent on activation of the small GTP-binding protein Rac1 (29) . Rac1 regulates the activity of the transcription factor nuclear factor (NF)-B via production of ROS (50) , believed to occur through the plasma membrane-bound superoxide (O 2 Ϫ ⅐)-generating NAD(P)H oxidase (1) . Under static conditions, neutrophil adhesion to anoxia (1 h)-reoxygenation (A/RO)-exposed human umbilical vein ECs (HUVECs) peaks at 30 and 240 min of reoxygenation: the early phase is mediated by transcription-independent upregulation of P-selectin and constitutively expressed intercellular adhesion molecule (ICAM)-1, and the late phase by transcription-dependent upregulation of E-selectin, P-selectin, and ICAM-1 (25) . Both phases are ROS dependent, because adhesion is attenuated by EC treatment with the chemical antioxidant N-acetylcysteine (NAC) (30) . The A/RO-induced activation of redox-sensitive transcription factors NF-B and activator protein (AP)-1 promotes the late phase by stimulating the expression of EC adhesion molecules (30) .
The fact that many EC adhesion molecules are upregulated after A/RO raised the possibility that the endothelium may support adhesion of other leukocyte subclasses, such as monocytes and lymphocytes, and that these cells may also mediate RP injury. In accordance with this, Kokura et al. (31) showed that Tlymphocyte adhesion to HUVECs increases after EC exposure to A (1 h)/RO (8 h) and that this hyperadhesivity is inhibited by antibodies against ICAM-1, vascular cell adhesion molecule (VCAM)-1, and their counterreceptors on T cells (␤ 2 -integrins for ICAM-1 and ␣ 4 -integrins for VCAM-1). In addition, a number of in vivo studies implicated monocytes in the pathogenesis of reperfusion injury. Birdsall et al. (6) found that ECs released monocyte chemoattractant protein (MCP)-1 that led to monocyte enrichment into the canine myocardium after reperfusion. Administration of an anti-MCP-1 antibody reduced infarct size in rat hearts (42) . Blocking the function of endothelial monocyte-activating polypeptide (EMAP)-II prevented the onset of apoptosis and the influx of monocytes in reperfused kidney (12) . Nevertheless, there is not yet an in vitro model that evaluates the molecular mechanisms of H/ROinduced monocyte adhesion to ECs.
Most in vitro studies on leukocyte adhesion to A/ROexposed ECs have been conducted under static conditions (25, 30, 31) , with few exceptions (17, 47) . Incorporating flow in the adhesion assay provides a more realistic environment for adhesion to occur, in which flowing cells have to form contacts within milliseconds with their counterligands and to withstand the shearing forces imposed by the flow (32) . Flow studies allow examination of the three types of adhesive interactions: tethering, rolling, and stable adhesion (39) . In addition, EC-released inflammatory mediators are washed away by flow, preventing the buildup of soluble mediators and leaving only the surface-bound molecules active.
In light of the advantages of in vitro flow systems, we studied the adhesive interactions between human monocytic U937 cells and H/RO-exposed HUVECs under a wall shear stress of 1 dyn/cm 2 , a level typically encountered in postcapillary venules (28, 49) . Kukreti et al. (33) studied monocyte adhesion to interleukin (IL)-1␤-stimulated ECs under flow and showed that L-selectin and ␣ 4 -integrins support rolling, whereas ␣ 4 -and ␤ 2 -integrins support stable adhesion. U937 cells are an appropriate model of monocytes in studying adherent interactions with ECs, because they express ␣ 4 ␤ 1 -and ␤ 2 -integrins as well as L-selectin (22, 24, 26, 46) . In A/RO-exposed HUVECs, VCAM-1 expression was shown to increase at 4 h after reoxygenation with a peak either at 12-16 h (57) or at 8 h (31). Because it remains unclear how and to what extent I/RP promotes monocyte adhesion, the objectives of the present study were 1) to quantify the U937 cell adhesive interactions to H (1 h)/RO (13 h)-exposed HUVECs, 2) to determine whether reoxygenation-induced ROS production promotes the expression of VCAM-1, 3) to investigate whether Rac1 activation is required for reoxygenation-induced ROS production, and 4) to clarify the role of VCAM-1 in monocytic cell-EC adhesive events.
Using the chemical antioxidant pyrrolidine dithiocarbamate (PDTC), which prevents NF-B activation (37) , we demonstrated that EC-derived ROS are involved both in VCAM-1 expression on H/RO-exposed HUVECs and in monocytic cell rolling and stable adhesion to these HUVECs. VCAM-1 was found to be solely responsible for stable adhesion, but it did not mediate rolling. The effects of H/RO exposure on VCAM-1 expression and U937 cell stable adhesion to H/RO-exposed ECs were completely blocked in ECs infected with an adenovirus that encodes a dominantnegative Rac1 (Rac1N17) but not with a control virus, suggesting that reoxygenation-induced ROS production is Rac1 dependent.
MATERIALS AND METHODS
U937 cell culture. U937 cells were purchased from American Type Culture Collection (ATCC, Rockville, MD) and cultured in RPMI 1640 with 25 mM HEPES (GIBCO BRL, Rockville, MD) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomycin (GIBCO). Cells were subcultured every 3 days until they reached a density of 10 6 /ml in assay medium (RPMI 1640 with 25 mM HEPES and 1% FBS).
EC tissue culture. Primary noncryopreserved HUVECs were purchased from GlycoTech (Rockville, MD) and grown in T25 flasks in EGM-2 complete growth medium containing 2% FBS and growth supplements (Clonetics, San Diego, CA). On confluence, cells were rinsed, trypsinized (0.05% trypsin solution, Clonetics), and seeded in different containers, depending on the experimental protocol. All culture containers were coated with 0.2% gelatin (Sigma, St. Louis, MO). For monocyte adhesion assays, second-passage ECs were grown in 35-mm tissue culture dishes (Corning, Corning, NY). For cell-based ELISA, ECs of second to fourth passage were grown in 24-well plates (Becton Dickinson). For measurement of O 2 Ϫ ⅐ production, ECs of second to fourth passage were grown in 60-mm tissue culture dishes (Becton Dickinson).
EC infection with recombinant adenoviruses. The replication-deficient adenovirus AdRac1N17, which encodes the myc epitope-tagged dominant-negative allele of Rac1, was constructed with homologous recombination in HEK 293 cells as previously described (50) . The control virus, Ad␤Gal, which encodes the bacterial LacZ gene, was also described previously (51) . Viruses were amplified in HEK-293 cells, purified on double cesium gradients, and plaque-titered (20) . Purified AdRac1N17 and Ad␤Gal had titers of 2 ϫ 10 10 and 5 ϫ 10 10 plaque-forming units (pfu)/ml, respectively. ECs were infected for 48 h before H/RO exposure (ϳ80% confluence) at a multiplicity of infection (MOI) of 150 in EGM-2 complete growth medium. No obvious change on cell morphology was observed. EC exposure to H/RO. Growth medium was removed, and a minimal amount of basal medium M199 (Gibco) was added in each container to decrease the diffusion distance for the atmospheric gases. Each container was exposed to a "hypoxic" gas mixture (5% CO 2-2% H2-93% N2; Puritan Bennett, Linthicum Heights, MD) in a humidified incubator (BillupsRothenburg, Del Mar, CA) for 1 h. The incubator was flushed with N 2 at a pressure of 2 psi for 15 min before switching to the hypoxic gas mixture. To ensure an oxygen-free environment, the gas mixture was passed through a catalytic deoxygenator (Gas Purification Technology, Manalapan, NJ) before entry to the incubator. On measurement of the partial pressure of O 2 with a Clark-style probe (Hudson RCI, Temecula, CA) placed in the fluid contained in the tissue culture container, the starting partial pressure was 150 mmHg and dropped to 10 mmHg (1% O 2 content) within 10 min of hypoxia. Temperature inside the incubator was maintained at 37°C by a heating pad and was monitored throughout hypoxia. After 1 h of hypoxia, reoxygenation was initiated by returning the cells to the regular tissue culture incubator (normoxia: 21% O 2-5% CO2-74% N2). EGM-2 complete growth medium was added 30 min from the onset of reoxygenation to maintain cell viability. Cell viability was deter-mined by trypan blue exclusion at 13 h from the onset of reoxygenation. Normoxic controls were exposed to normoxia for the duration of the experiment. PDTC (100 M) was added to some monolayers 60 min before hypoxia. To some monolayers, a monoclonal antibody against VCAM-1 (1G11; Immunotech, Fullerton, CA), which was shown to inhibit U937 cell adhesion to tumor necrosis factor (TNF)-␣-stimulated ECs (55) , was added at a final concentration of 40 g/ml for 30 min before completion of reoxygenation.
Cell-based ELISA for VCAM-1. At the end of 13-h reoxygenation or normoxia, VCAM-1 expression was determined by a cell-based ELISA. Briefly, monolayers were fixed with ice-cold ethanol for 10 min and nonspecific binding was blocked by adding I-block (Tropix, Bedford, MA) in PBS for 1 h at 37°C. Subsequently, 200 l of mouse monoclonal anti-human VCAM-1 (1:2,500 dilution; R&D Systems, Minneapolis, MN) were added to each well and incubated overnight at 4°C. Monolayers were washed in PBS, incubated with biotin-conjugated goat anti-mouse IgG (1:2,500 dilution; Zymed, San Francisco, CA) in PBS for 1 h at room temperature, washed, and incubated with horseradish peroxidase (HRP)-conjugated streptavidin (1:5,000 dilution) in PBS for 30 min at room temperature. After washing with PBS, 200 l of tetramethyl benzidine substrate solution (TMB; Sigma) were added to each well for 10 min. The reaction was stopped with 50 l of 8 N H 2SO4, and the plates were read on a spectrophotometric plate reader at 450 nm. The mean optical density (OD) of the wells containing normoxic cells without primary antibody was considered as background OD and was subtracted from all other readings. For each condition, measurement of triplicate wells was made to obtain an average value.
Flow adhesion assay. Each 35-mm tissue culture dish with a cell monolayer formed one side of a parallel-plate perfusion chamber (GlycoTech), with a flow path of 0.025-cm thickness and 0.1-cm width, as determined by a silicone gasket (GlycoTech). The tissue culture dish and the flow deck were kept together by vacuum. The perfusion chamber and inlet and outlet tubing were filled with assay medium and maintained at 37°C by a thermostatic air pump (Nikon, Garden City, NY). A syringe pump (Harvard Apparatus, South Natick, MA) was used to perfuse first assay medium for 2 min and then a suspension of U937 cells in assay medium for 5 min through the chamber at a constant flow rate of 0.64 ml/min. The viscosity of the assay medium was assumed to be 0.01 g ⅐ cm Ϫ1 ⅐ s Ϫ1 . By considering fully developed steady laminar flow of a viscous Newtonian fluid (5), the wall shear stress on the monolayer was calculated at 1 dyn/cm 2 , as previously described (23, 49) . The perfusion chamber was mounted on an inverted-stage microscope (Diaphot 300; Nikon) equipped with a video camera (CCD-72S; MTI, Michigan City, IN). Stage movement was controlled in the x and y directions with two micro-stepping motors (Multitech, West Chester, PA). For each experiment, three random microscopic fields (ϫ20 objective, 0.38 mm 2 /field) close to the chamber inlet were chosen for recording the U937 cell-EC adhesive interactions for 90 s per field with a JVC sVHS videocassette recorder (Professional Products, Baltimore, MD). Nine experimental conditions were tested by flow adhesion assay: 14-h normoxia (N); 1 h with PDTC and 14-h normoxia (N-PDTC); infection with Ad␤Gal and 14-h normoxia (N-␤Gal); infection with AdRac1N17 and 14-h normoxia (N-Rac); 1-h hypoxia followed by 13- 
h reoxygenation (H/R); 1 h with PDTC and H (1 h)/RO (13 h) (H/R-PDTC); infection with Ad␤Gal and H (1 h)/RO (13 h) (H/R-␤Gal); infection with AdRac1N17 and H (1 h)/RO (13 h) (H/R-Rac); and H (1 h)/RO (13 h) and 30 min with anti-VCAM-1 (H/R-VCAM).

Quantitation of monocytic cell-EC adhesive interactions.
Video recordings from flow adhesion assays were digitized, and quantitative information was obtained by image processing (IC-300 modular image processing workstation; Inovision, Durham, NC). The total of U937 interacting cells per minute was defined as the number of cells that interacted with the monolayer in the digitized image (0.38 mm 2 ) for at least 1 s and included cells that tethered, rolled, and stably adhered. Brief contacts for Ͻ2 s were identified as tethering. Rolling cells were identified by acquiring "maximization" images for 3-5 s at 30 frames/s, as described previously (27) . Rolling velocities in micrometers per second were determined by dividing the distances traveled by the acquisition time. Data from n ϭ 4 independent experiments were pooled to give rolling velocities for 60 rolling monocytes for each condition tested. The frequency of occurrence for each velocity range was presented as a percentage relative to the total number of examined monocytes. Cells were defined as stably adherent if they remained attached to the monolayer for at least 5 s. Stably adherent cells were identified by acquiring "minimization" images for 5 s at 30 frames/s, as described previously (27) , and were not included in the rolling cells. Distribution charts of the three interaction types were presented as a percentage of the total of interacting cells. Cells that interacted with other rolling or stably adherent cells before interacting with ECs were not accounted for, to study only primary adhesive events.
Measurement of EC ROS production. Lucigenin, a compound that emits light upon interaction with O 2 Ϫ ⅐ (21), was used to measure EC O 2 Ϫ ⅐ production, as described previously (4) . Specifically, at 5 min of reoxygenation, ECs were harvested in PBS and cell pellets were suspended in a balanced salt solution consisting of (in mM) 130 NaCl, 5 KCl, 1 MgCl 2, 1 CaCl2 ⅐ 2H2O, 35 H3PO4, and 20 HEPES, pH 7.4. The viability of the suspended cells was Ͼ95% as determined by trypan blue exclusion. EC suspensions were added at room temperature to triplicate wells of 96-well plates containing dark-adapted lucigenin (250 M) in balanced salt solution. Increases in photon emission were measured every 20 s thereafter for 7 min in a scintillation counter (Top counter; Packard Instrument, Meriden, CT). Net increases in O 2 Ϫ ⅐ generation were calculated by comparison with a standard curve generated with xanthine/xanthine oxidase and normalized by protein content obtained from a protein assay (bicinchoninic acid; Pierce, Rockford, IL).
Statistical analysis. The number of cells per minute that tethered, rolled, or stably adhered are presented as means Ϯ SE for n ϭ 4 independent experiments in each condition. ODs from the ELISA assay were normalized to their corresponding normoxic controls and are presented as means Ϯ SE for n ϭ 4 independent experiments in each condition. Statistical significance of differences among means was determined using Statview software (Abacus Concepts, Berkeley, CA) to perform one-way ANOVA with Bonferroni corrections for multiple comparisons. P values Յ0.05 were considered significant.
RESULTS
U937 cell adhesion to H/RO-exposed ECs: role of ROS.
Three types of adhesive interactions between U937 cells and ECs, namely, tethering, rolling, and stable adhesion, were quantified (n ϭ 4; Fig. 1, A-C) . Under normoxic conditions (N), tethering was the predominant type of interaction, accounting for 80% of total interacting cells (Fig. 1D) . The interaction ap-peared to be nonspecific, because H (1 h)/RO (13 h) did not increase tethering (Fig. 1A) . Under N, the frequency of rolling and stable adhesion accounted for 20% and 1%, respectively, of total interacting cells (Fig.  1D ). H/RO-exposed ECs (H/R) were capable of supporting significantly higher fluxes of rolling and stably arrested cells: rolling increased 5.6-fold and stable adhesion increased from 0.1 to 2.3 cells/min, relative to N (Fig. 1, B and C) . Rolling cells became the dominant interacting cell type after H/RO, accounting for Ͼ50% of total interacting cells compared with 20% under N (Fig. 1D) . Almost all monocytes that were arrested onto the monolayer had previously rolled on it. The majority of rolling cells, however, later detached and reentered the fluid stream. Rolling cells appeared spherical, whereas many stably adherent cells were less regular in shape. Rarely, a stably adherent cell (cell arrested for at least 5 s) was later released and resumed rolling. No transmigrating cells were observed in these experiments.
To investigate the possible role of ROS in H/ROinduced monocyte adhesion, PDTC (100 M) was incubated with ECs for 1 h before hypoxia. PDTC scavenges ROS by raising reduced glutathione levels inside the cells and was shown to inhibit NF-B activation by preventing its mobilization (55) . PDTC pretreatment of normoxic controls (N-PDTC) did not affect the flux of tethering or stably adherent cells compared with N (n ϭ 4; Fig. 1, A and C) . PDTC pretreatment decreased rolling, but the difference was not significant (n ϭ 4; Fig. 1B) . Moreover, PDTC significantly decreased rolling after H/RO (H/R-PDTC): the rolling flux dropped to 5.6 cell/min vs. 14.8 cells/min after H/RO (Fig. 1B) . Compared with its normoxic counterpart (N-PDTC), the rolling flux was still 5-fold higher, resembling the 5.6-fold increase seen with the non-PDTC-treated pair (N, H/R). In contrast to rolling, the H/RO-induced increase in the flux of stably adherent cells was completely abolished by PDTC (Fig. 1C) . In H/R-PDTC samples, the distribution of interactions returned to tethering dominant, as it was under N (Ͼ70%; Fig. 1D ). It is possible that ROS regulate both the induction of adhesion molecule(s) that is (are) involved in H/ROinduced rolling and stable adhesion and even the expression of adhesion molecule(s) that is (are) involved in basal rolling.
Role of Rac1 in U937 cell adhesion to H/RO-exposed ECs. Because Rac1 is an integral part of the NAD(P)H oxidase complex and regulates ROS production in phagocytic and nonphagocytic cells (1, 29, 52 ), we asked whether monocytic cell adhesion to H/RO-exposed ECs was dependent on Rac1-mediated ROS production (n ϭ 4; Fig. 2 ). Normoxic HUVECs infected with either AdRac1N17 (N-Rac) or Ad␤Gal (N-␤Gal) showed the same distribution of the three types of U937 cell-EC adhesive interactions, as in noninfected N cells (Fig. 2D) . Specifically for rolling and stable adhesion, there was no significant difference between N-Rac and N-␤Gal conditions (Fig. 2, B and C) . For tethering, there was a decrease in N-Rac compared with N-␤Gal conditions, but it was not significant ( Fig.  2A) . After H/RO exposure of Ad␤Gal-infected ECs (H/R-␤Gal), tethering was not affected (Fig. 2A) . In contrast, H/R-␤Gal cells showed a 3-and 10-fold increase in rolling and stable adhesion, respectively (Fig.  2, B and C) . In H/R-␤Gal cells, the distribution of interaction types was skewed toward rolling, with 50% of total interacting cells being rolling cells, as in noninfected H/R cells (Fig. 2D ). Inhibition of Rac1 in H/ROexposed ECs (H/R-Rac) significantly reduced the rolling flux by 62%, compared with its H/RO-exposed counterpart H/R-␤Gal (Fig. 2B) . In H/R-Rac cells, the rolling flux was 1.7-fold higher than in N-Rac cells (Fig.  2B) . Inhibition of Rac1 also resulted in complete inhibition of stable adhesion after H/RO (compare H/R␤Gal and H/R-Rac, Fig. 2C) . In H/R-Rac cells, the distribution of interaction types became as it was in N and H/R-PDTC cells (tethering accounted for 60% of total interacting cells; Fig. 2D ). Hence, Rac1 activation may be required for rolling and stable adhesion after H/RO but is not required for adhesive interactions under normoxia (both N-␤Gal and N-Rac showed the same rates of tethering, rolling, and stable adhesion).
EC O 2 Ϫ ⅐ generation after H/RO. The effects of PDTC treatment or Rac1 inhibition on H/RO-induced EC O 2
Ϫ ⅐ generation were studied by lucigenin chemiluminescence at 5 min after reoxygenation. A characteristic run, from two identical runs, is shown in Fig. 3 . Under normoxia, there was a low basal level of O 2 Ϫ ⅐ generation that was slightly affected by PDTC treatment or Ad␤Gal infection. AdRac1N17 infection led to even lower basal O 2 Ϫ ⅐ production (60% compared with N). EC O 2 Ϫ ⅐ generation increased more than twofold in both H/R and H/R-␤Gal cells, suggesting that O 2 Ϫ ⅐ is one ROS that is greatly overproduced shortly after reoxygenation. Either PDTC treatment (H/R-PDTC) or infection with AdRac1N17 (H/R-Rac) markedly, but not completely, blocked the H/RO-induced increase in O 2 Ϫ ⅐ production (Fig. 3) . The changes in O 2 Ϫ ⅐ production under different conditions appear to correspond to changes in U937 cell rolling and stable adhesion, suggesting that H/RO-induced O 2 Ϫ ⅐ production may play a role in the expression of EC adhesion molecules for monocytes.
EC VCAM-1 expression after H/RO. Because VCAM-1 is involved in monocyte-EC adhesive events under flow (33) and is known to be upregulated by H/RO (31, 57), we studied EC VCAM-1 expression under different conditions by cell ELISA (n ϭ 4; Fig. 4 ). In N-␤Gal cells, there was a slight, but not significant, increase in VCAM-1 expression compared with N cells. Either PDTC treatment (N-PDTC) or infection with AdRac1N17 (N-Rac) downregulated the basal VCAM-1 expression compared with that of their respective controls (N, N-␤Gal), but the difference was not significant. Exposure to H/RO increased VCAM-1 expression almost twofold in both infected and noninfected cells. PDTC treatment (H/R-PDTC) inhibited by 75% and infection with AdRac1N17 (H/R-Rac) almost completely abolished the H/RO-induced increase in VCAM-1 expression compared with H/R and H/R-␤Gal, respectively (Fig. 4) . Thus H/RO-induced VCAM-1 expression is regulated by Rac1-dependent ROS.
Role of VCAM-1 in U937 cell adhesion to H/ROexposed ECs. Because VCAM-1 supports monocyte stable adhesion to cytokine-stimulated ECs (33) and has been implicated in tethering and rolling (2, 3, 33) , we studied the VCAM-1 contribution to U937 cell adhesive interactions with H/RO-exposed ECs by using a blocking anti-VCAM-1 monoclonal antibody (n ϭ 4; Fig. 5 ). Incubation with anti-VCAM-1 antibody 1G11 (40 g/ ml) for 30 min before completion of 13 h of reoxygenation (H/R-VCAM) did not affect the tethering flux (Fig. 5A) . Incubation with anti-VCAM-1 antibody resulted in a measurable (40%), but not significant, increase in rolling flux compared with H/R (Fig. 5B) . Furthermore, it completely abolished H/RO-induced stable adhesion, indicating a crucial role of VCAM-1 in monocytic cell stable adhesion (Fig. 5C ). The shift in distribution of interaction types from tethering to rolling, observed in H/R, was maintained in H/R-VCAM, with rolling accounting for Ͼ60% of total interactions (Fig. 5D) . In H/R-VCAM, not only did the flux of rolling cells increase compared with H/R (Fig. 5B) , but the mean rolling velocity also slightly decreased. Figure 6 shows the distribution of rolling velocities of U937 cells perfused at 1 dyn/cm 2 over ECs exposed to different conditions (N, H/R, or H/R-VCAM; n ϭ 4). Under N conditions, cells rolled at a mean rolling velocity of 133 Ϯ 8 m/s (ϮSE; Fig. 6A ). H/R caused cells to roll significantly more slowly, at 88 Ϯ 8 m/s on average (ϮSE; Fig. 6B ). H/R-VCAM resulted in further skewing of the distribution of rolling velocities to the low side: the mean rolling velocity was 79 Ϯ 8 m/s (ϮSE; Fig.  6C) , which was significantly different from N but not significantly different from H/R.
DISCUSSION
The present study provides the first evidence that 1) flowing monocytic cells will roll and firmly adhere to H/RO-exposed ECs, 2) stable adhesion is totally, and rolling partially, dependent on Rac1-mediated ROS production, and 3) VCAM-1 mediates stable adhesion, but not rolling, of monocytic cells to H/RO-exposed ECs. By incorporating flow in the adhesion assay, it is possible not only to observe and quantify each step in the cascade of adhesive events (tethering, rolling, and stable adhesion) but also to determine the molecular mechanisms that regulate individual steps.
Tethering was the most prominent adhesive interaction type under normoxia (Fig. 1D) . These brief contacts of monocytic cells with HUVEC monolayers cause a temporary halt in the movement of flowing cells, and although most are instantly released back to the fluid stream, some start to roll on the EC surface. Rolling decelerates the monocytes, allowing them to sample the local environment and interact with EC receptors that mediate firm arrest. A limited flux of stably adherent cells was observed under N conditions (Fig. 1C) . EC exposure to H (1 h)/RO (13 h) significantly increased the fluxes of rolling and stably adherent cells, compared with N, while maintaining the same tethering flux (Fig. 1, A-C) . Rolling and stable adhesion fluxes increase when monocytes are perfused over cytokine-stimulated ECs (33, 36) . The flux of stably adherent U937 cells to H/RO-exposed HUVECs was low (ϳ5 cells ⅐ mm Ϫ2 ⅐ min Ϫ1 at 1 dyn/cm 2 ) compared with that of human peripheral blood monocytes to either 4-h IL-1␤-stimulated HUVECs (ϳ15 cells ⅐ mm Ϫ2 ⅐ min Ϫ1 at 2 dyn/cm 2 ; Ref. 33) or 24-h IL-4-stimulated HUVECs (ϳ60 cells ⅐ mm Ϫ2 ⅐ min Ϫ1 at 0.8 dyn/cm 2 ) (36). Consistent with this finding, Kokura et al. (31) showed that A (1 h)/RO (8 h) induces an increase in (static) T-lympho- EC O 2 Ϫ ⅐ generation increased shortly after reoxygenation (Fig. 3) , in agreement with data on H/RO-induced ROS production monitored by the oxidant-sensitive fluorescent probes 2,7-dichlorofluorescein diacetate and dihydrorhodamine 123 (9, 29) . The fact that treatment with PDTC or infection with AdRac1N17 attenuated, without blocking completely, the H/RO-induced O 2 Ϫ ⅐ generation implies that there are intracellular, e.g., mitochondrial, ROS sources inaccessible by PDTC and H/RO-stimulated O 2 Ϫ ⅐-generating pathways independent of Rac1. The degree of inhibition of O 2 Ϫ ⅐ production in H/R-PDTC was slightly higher than that in H/R-Rac (81% vs. 72%) compared with corresponding controls (Fig. 3 ). This suggests that 1) PDTC treatment probably eliminates most of the O 2 Ϫ ⅐ generated by the Rac1-regulated oxidase and 2) the Rac1-regulated oxidase is the main source of O 2 Ϫ ⅐ generation upon EC stimulation by H/RO. However, because ECs were infected with AdRac1N17 at a MOI of 150 and higher MOI were not tried (Յ200; Ref. 13) , there is also a possibility that Rac1N17 expression may have not blocked the NAD(P)H oxidase activity entirely.
EC treatment with PDTC significantly attenuated H/RO-induced rolling and completely abolished stable adhesion (Fig. 1, B and C) , suggesting that ROS regulate monocytic cell rolling and stable adhesion to H/RO-exposed ECs. PDTC also decreased rolling under N, but the difference was not significant (Fig. 1B) , implying that ROS may, in part, regulate the expression of a constitutively expressed adhesion molecule involved in rolling. Normoxic ECs infected with either AdRac1N17 or Ad␤Gal showed the same rolling and stable adhesion fluxes and similar tethering fluxes (Fig. 2) . Infection with AdRac1N17 significantly reduced the H/RO-induced increase in rolling and completely abolished the H/RO-induced increase in stable adhesion compared with H/RO-exposed ECs infected with Ad␤Gal (Fig. 2) , suggesting that the Rac1-dependent ROS mainly regulate monocytic cell rolling and exclusively regulate stable adhesion. Specifically for rolling, AdRac1N17 was more potent than PDTC in attenuating H/RO-induced rolling, compared with their respective N counterparts (1.7-fold with H/R-Rac vs. 3.4-fold with H/R-␤Gal; 5-fold with H/R-PDTC vs. 5.6-fold with H/R). This implies that Rac1-regulated ROS-independent signaling pathways contribute to the H/RO-induced increase in rolling. Similarly, chemical antioxidants were shown to be effective at suppressing H/RO-induced heat shock factor (HSF) activation but not as effective as Rac1N17, implying that Rac1-dependent ROS-independent mechanisms partially regulate HSF-mediated transcription (44) , leading to attenuation of proinflammatory responses (54) .
From the measurements of EC viability at 13 h of reoxygenation (complete growth medium was added back to ECs at 30 min of reoxygenation), the adhesive interactions between a fraction of ECs in the monolayer and U937 cells are not due to EC death. Neither PDTC nor Rac1 inhibition, with or without H/RO exposure, caused cell death, because Ͼ90% cells were viable in each case. Furthermore, the continuation of the monolayers was always checked under the microscope right before the flow adhesion assay. In accordance with this, there is evidence that 1) EC infection with AdRac1N17 at MOIs of 50-200 does not cause apoptosis (13) , 2) incubation of confluent HUVECs with PDTC (100 M) for 24 h does not induce cell death (14) , and 3) infection with AdRac1N17 protects HUVECs from H/RO-induced cell death (29) . Hence, although we have not tested specifically for apoptosis, we know that our studies were performed with viable ECs.
Because VCAM-1 mediates monocyte adhesive interactions with cytokine-stimulated ECs under flow (33) and antioxidants inhibit NF-B activation and VCAM-1 expression on cytokine-stimulated ECs (37, 55), we evaluated the effect of H/RO, and the importance of H/RO-induced Rac1-dependent ROS, on VCAM-1 ex- pression. In agreement with published studies on the time course of VCAM-1 on HUVECs exposed to A (1 or 4 h)/RO (31, 57), we found a twofold increase in VCAM-1 expression at 13 h of reoxygenation (Fig. 4) . H/RO-induced VCAM-1 upregulation was significantly attenuated by PDTC and almost completely abolished by AdRac1N17 (Fig. 4) , suggesting that VCAM-1 expression is mainly regulated by Rac1-dependent ROS. NF-B and, to a lesser extent, AP-1 are involved in A/RO-induced VCAM-1 expression (31). Because Rac1-mediated ROS are a major part of total ROS (Fig. 3) and both NF-B DNA binding activity and the turnover of the inhibitor IB are oxidant sensitive (18) , it is possible that Rac1-mediated ROS regulate NF-Bdriven gene expression. There are downstream effectors of Rac1, however, that may also be important in regulating H/RO-induced expression of VCAM-1: Rac1 has been implicated in activation of members of the family of mitogen-activated protein (MAP) kinases, such as p38 (60) and the extracellular signal-regulated kinases (ERK1/2) (59), and these MAP kinases are required for NF-B-driven gene expression (7, 8) . The GTPases Rac1 and Cdc42 are also known to regulate a protein kinase cascade initiated at p21-activated kinase (Pak)-1 and leading to activation of c-Jun NH 2 -terminal kinase (JNK) and p38 MAP kinase (10, 60) . Hence, it is possible that each of the above effectors, as well as the actin cytoskeleton (11), differentially regulate VCAM-1 expression.
Because blocking VCAM-1 completely abolished firm adhesion (Fig. 5C ), VCAM-1 is the sole mediator of monocytic cell firm adhesion to H/RO-exposed HUVECs. This agrees with the fact that blocking ␣ 4 ␤ 1 significantly reduced firm adhesion of flowing monocytes to IL-1␤-stimulated HUVECs, whereas blocking ␤ 2 -integrins (hence, ICAM-1-mediated pathway) did not (33) . A limited number of U937 cells were arrested on H/ROexposed ECs without prior rolling, suggesting that VCAM-1 is capable of firm adhesion even in the absence of selectin-mediated adhesive interactions. The ␣ 4 ␤ 1 -VCAM-1 interaction can precede activation events that are required for development of firm adhesion (2, 15, 58) . From our findings, however, VCAM-1 does not mediate tethering or rolling (Fig. 5, A and B) . The surface density of VCAM-1 after H/RO, despite being higher than basal, may not be high enough to increase the avidity between ␣ 4 ␤ 1 and VCAM-1 to mediate tethering or rolling.
Rolling markedly increased in the presence of saturating concentrations of anti-VCAM-1 antibody compared with H/R (Fig. 5B) . Increased rolling flux may be due to decreased firm adhesion upstream of the field of view, thus more rolling cells enter the field per unit time. This agrees with the data of Weber et al. (56) , who inhibited NF-B mobilization by overexpression of IB in HUVECs and found that reduced induction of VCAM-1/ICAM-1 by TNF-␣ resulted in a decrease in the ability of monocytes to firmly adhere and an increase in the rolling fraction of monocytes. However, in our case, the increase in rolling cells after VCAM-1 blockade cannot be accounted for solely by the reduction in stably adherent cells, as can be seen by comparing Fig. 5 , B and C. The increased flux of rolling monocytes combined with the reduced rolling velocities after VCAM-1 blockade (Fig. 6 ) suggest a greater number of receptor-ligand bonds. Antibody cross-linking of VCAM-1 on the EC surface induces a Ca 2ϩ flux (48) and activates NAD(P)H oxidase to produce ROS (38) . Hence, VCAM-1-mediated outside-in signaling may cause rapid expression of the oxidant-sensitive preformed P-selectin from Weibel-Palade bodies (45) , or of a novel receptor, leading to increased rolling interactions and reduced rolling velocities.
The U937 cell mean rolling velocity over H/RO-exposed HUVECs is comparable to that of monocytes over (24 h) IL-4-stimulated HUVECs (36) but is higher than that of monocytes over either (4 h) IL-1␤-or (6 h) TNF-␣-activated HUVECs (33, 35) . Rolling is probably mediated by L-selectin binding to sialylated determinants on the EC surface, as in the case of monocytes rolling over IL-1␤-stimulated HUVECs (33) . At 13 h of reoxygenation, P-and E-selectin are not likely to be present on the EC surface, because their expression levels were shown to return to basal levels at 10 h of reoxygenation (25) and neither of the two affected static T-lymphocyte adhesion at 8 h of reoxygenation (31) .
Under our experimental conditions, besides exposure to hypoxia, ECs were exposed to serum/growth factor deprivation for 1 h during hypoxia (and the first 30 min of reoxygenation), to make hypoxia more physiologically relevant to ischemia. Because of the short time period of serum/growth factor withdrawal, it is believed that the effects of our treatment on EC signaling and EC-leukocyte adhesive events are for the most part due to H/RO exposure. In sum, we demonstrated that flowing monocytic cells tether, roll, and firmly adhere to cultured HUVECs exposed to H/RO. EC Rac1-dependent ROS partially regulate rolling and exclusively regulate stable adhesion. Stable adhesion, but not rolling, is mediated by induction of VCAM-1 expression. In vivo, physical and biological factors not present in our in vitro system may modulate leukocyte adhesion within the range of physiological shear stresses (40) . In vitro systems, however, are still very useful in subjecting cultured ECs to well-defined flow conditions and in understanding the molecular basis underlying the leukocyte response to ECs after I/RP injury.
